University of Dundee

The AMR Accelerator, a public-private partnership, aims to accelerate antibiotic development and build research capabilities for treating resistant infections. It has progressed 44 antibacterial programmes, developed research infrastructures, and fostered cross-project networks. Challenges include collaboration complexities, ensuring synergies, and sustainability of assets post-project. The initiative calls for long-term funding to sustain expertise and attract new talent to the field.

Zambon announces Phase 3 PROMIS-I and PROMIS-II study results in The Lancet Respiratory Medicine, showing inhaled colistimethate sodium via I-neb reduced pulmonary exacerbations in Non-Cystic Fibrosis Bronchiectasis patients chronically colonized with P. aeruginosa.

Fear of low blood sugar prevents many with type 1 diabetes from exercising, but education on managing diabetes during workouts can encourage participation, according to a study presented at the European Association for the Study of Diabetes annual meeting.